Trusted Press Release Distribution   Plans | Login    

Briefing Search


Author Details
Suite 9884 27 Upper Pembroke Street, Dublin 2

Bookmark and Share
Actigraphy Sensors & PSG Devices Market Set to Deliver Major Revenue Shares during 2018-2026
This report provides prognosis and analysis of the Actigraphy Sensors & PSG Devices Market. It offers historical data along with forecast data for 2026.

Fact.MR, 3/15/2019 - The purpose of this rich study presented by FactMR is to elaborate the various market projections impacting the global Actigraphy Sensors & PSG Devices Market during the period until 2026. This assessment delivers high-end statistics concerning market size (US$ Mn), Y-o-Y growth and revenue share (US& Mn) linked to different geographies and segmentation types. Readers can acquire precise insights about growth trends along with opportunities that are expected to reshape the overall structure of the Actigraphy Sensors & PSG Devices Market during the forecast period.

Get Sample PDF Illustration Here –

FactMR report provides comprehensive information about recent developments in the competitive environment in the actigraphy sensor and PSG devices market. Stakeholders in the actigraphy sensor and PSG devices market featured in the FactMR report are Koninklijke Philips N.V., Fitbit, Inc., Garmin Ltd., Aetna Inc., ResMed Inc., BMC Medical Co., Ltd., Activinsights Ltd., SOMNOmedics GmbH, MEDISANA GmbH, Recorders & Medicare Systems Pvt Ltd, Compumedics, Ltd., Natus Medical, Inc., Cleveland Medical Devices Inc., Cidelec, iHealth Labs Inc., Medicom MTD, ActiGraph, LLC, and Nox Medical.

Tier I Companies Hold a Whopping 70% Revenue Share in the Actigraphy Sensor and PSG Devices Market

The actigraphy sensor and PSG devices market is witnessing positive growth with the frontrunners accounting for nearly two-third of the total revenue in the market. Frontrunners in the actigraphy sensor and PSG devices market, including Koninklijke Philips N.V., Fitbit, Inc., Garmin Ltd., and ResMed Inc., have maintained a strong foothold in the market.

Apart from the launch of next-generation actigraphy sensor and PSG devices, inorganic growth strategies have been instrumental in driving the market share of Tier I companies. Large companies, including ResMed, Fitbit Inc., and Garmin Ltd., have been collaborating with or acquiring small and medium enterprises in the actigraphy sensor and PSG devices market for consolidating their position. Further, challenges associated with regulatory compliance have meant that actigraphy sensor manufacturing has remained highly consolidated.

The modern lifestyle has altered sleeping patterns, leading to an increase in the prevalence of various sleep disorders. Right from minor sleep disturbances to major problems, such as insomnia, chronic sleep disorders have adverse impacts on consumers’ quality of life. As actigraphy sensor and PSG devices make it simpler for users to monitor their sleep duration with more convenience and accuracy, it helps in diagnosing sleep diseases reliably and makes treatments more effective.

Browse Complete Report Here –

Thereby, consumers are seeking diagnostic services for the accurate treatments of sleep disorders, which is creating a high demand for actigraphy sensor and PSG devices in the healthcare sector. Furthermore, ongoing research in the field of sleep disorder management to discover more efficient medicine and treatments for life-threatening sleep disorders is providing a boost to the applications of actigraphy sensor and PSG devices.

FAQs | Contact Us | Terms & Conditions | Privacy Policy
© 2019 Proserve Technology, Inc.